BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

Stig Larsen,1 Kritiya Butthongkomvong,2 Alexey Manikhas,3 Ekaterina Trishkina,4 Elena Poddubuskaya,5 Marina Matrosova,6 Vichien Srimuninnimit,7 Steen Lindkær-Jensen81Department of Controlled Clinical Trials and Biostatistics, Centre for Epidemiology and Biostatistics, University of Life S...

Full description

Bibliographic Details
Main Authors: Larsen S, Butthongkomvong K, Manikhas A, Trishkina E, Poddubuskaya E, Matrosova M, Srimuninnimit V, Lindkær-Jensen S
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:Breast Cancer : Targets and Therapy
Online Access:http://www.dovepress.com/bp-c1-in-the-treatment-of-patients-with-stage-iv-breast-cancer-a-rando-peer-reviewed-article-BCTT

Internet

http://www.dovepress.com/bp-c1-in-the-treatment-of-patients-with-stage-iv-breast-cancer-a-rando-peer-reviewed-article-BCTT

Similar Items